QuickView for BRCA2;jsessionid=4743BD6FAA6C4B3AEABAF5593E96A0A2;jsessionid=F80CDFCEEC649DED6D817DAEA6919426;jsessionid=A2EE12DD7ABF8BCF4F94A848506A90D5;jsessionid=6B1017360A26BCE982E43F93CF573C03;jsessionid=DF5FCF8685B7BEF78AF8801F4A5D4650;jsessionid=3F89D405644B96C7759A5772E8F2333B;jsessionid=D6F9E34171370B9BCB6FEC1717091DCE (gene)

1. Non-BRCA1/BRCA2 high-risk familial breast cancers are not associated with a high prevalence of BRCAn…
2. Risk of metastasis in BRCA2 carriers diagnosed with triple-negative breast cancer.
3. Alterations in BRCA2 as Determinants of Therapy Response in Prostate Cancer.
4. Frequency and distribution of BRCA1/BRCA2 large genomic rearrangements in Turkish population with br…
5. Analysis of BRCA1 and BRCA2 alternative splicing in predisposition to ovarian cancer.

There were no clinical trials for BRCA2;jsessionid=4743BD6FAA6C4B3AEABAF5593E96A0A2;jsessionid=F80CDFCEEC649DED6D817DAEA6919426;jsessionid=A2EE12DD7ABF8BCF4F94A848506A90D5;jsessionid=6B1017360A26BCE982E43F93CF573C03;jsessionid=DF5FCF8685B7BEF78AF8801F4A5D4650;jsessionid=3F89D405644B96C7759A5772E8F2333B;jsessionid=D6F9E34171370B9BCB6FEC1717091DCE